期刊文献+

Fibulin-5真核表达载体的构建及稳定转染人膀胱癌细胞的研究 被引量:1

Construction of Fibulin-5 eukaryotic expression vector and establishment of its stable transfected bladder cancer cell line
原文传递
导出
摘要 目的构建Fibulin-5真核表达载体并转染人膀胱癌5637细胞。方法经聚合酶链反应(PCR)扩增Fibulin-5cDNA,然后将其与pMD-19T载体连接。pMD-19T—Fibulin-5重组体经过限制性内切酶XhoI和EcoRⅠ的消化后产生XhoⅠ-Fibulin5-EcoRⅠ片段。将该片段插入增强型绿色荧光蛋白载体(p-EGFPN1)质粒的相似位点并最终合成p-EGFP—F5质粒重组体,并通过BgⅢ单酶切鉴定。通过脂质体介导法将p-EGFP-F5质粒转染至人膀胱癌5637细胞株内。结果PCR扩增片段长度为1429bp。XhoⅠ和EcoRⅠ双酶切的片段经DNA测序显示Fibulin-5cDNA插入正确。p-EG—FP—F5质粒重组体经BgⅢ单酶切出一约450bp的条带。转染48h后,pEGFP—Fibulin-5和pEGFP—N1转染成功的细胞均有不同程度的绿色荧光表达。结论成功构建Fibulin-5绿色荧光蛋白真核表达载体并转染至人膀胱癌细胞内。 Objective To construct eukaryotic expression vector of Fibulin-5 and establish stable human bladder cancer cell line. Methods Fibulin-5 cDNA in hDANCE_CFLAG plasmid was amplified by polymerase chain reaction (PCR). The amplified products were cloned into pMD-19T simple vector. The pMD-19T-Fibulin-5 vector was cut by Xho Ⅰ and EcoR I to generate a Xho I-FibulinS-EcoR I fragment that was ligated into enhanced green fluorescent protein carrier ( p-EGFP-N1 ) plasmid to synthesize p-EGFP- Fibulin-5 plasmid, which was then cut by Bg Ⅲ. Finally, the p-EGFP-Fibulin-5 plasmid was transfected into bladder cancer cell line 5637 by liposomes. Results The length of PCR products was 1429 bp. The results of DNA sequencing for the fragments by Xho Ⅰ and EcoR Ⅰ suggested the correct insertion of Fibulin- 5 eDNA. A band with about 450 bp was generated after p-EGFP-Fibulin-5 plasmids were digested by BgⅢ. The successfully transfected cells by pEGFP-Fibulin-5 or pEGFP-N1 emitted green fluorescence. Conclusion Fibulin-5 eukaryotie expression vector was successfully constructed and transfected to human bladder cancer cell line.
出处 《中华实验外科杂志》 CAS CSCD 北大核心 2012年第4期696-698,共3页 Chinese Journal of Experimental Surgery
关键词 膀胱癌 真核表达载体 转染 FIBULIN-5 Bladder carcinoma Eukaryotic expression vector Transfeetion Fibulin-5
  • 相关文献

参考文献3

二级参考文献5

共引文献7

同被引文献11

  • 1王国民,胡礼炳.膀胱肿瘤实验研究发展方向[J].中华实验外科杂志,2006,23(10):1157-1158. 被引量:7
  • 2邹钧,钟惟德.CD147在肿瘤转移和临床诊治的研究进展[J].中华实验外科杂志,2007,24(7):893-894. 被引量:4
  • 3Siegel R, Ma J, Zou Z, et al. Cancer statistics 2014 [J]. CA Cancer J Clin, 2014,64( 1 ) :9 - 29.
  • 4Schiemann WP, Blobe GC, Kalume DE, et al. Context -specificeffects of fibulin - 5 (DANCE/EVEC) on cell proliferation, motil- ity, and invasion. Fibulin -5 is induced by transforming growth factor- beta and affects protein kinase cascades [ J ]. J Biol Chem, 2002,277 (30) :27369 - 27377.
  • 5Loeys B, Van - Maldergem L, Mortier G, et al. Homozygosity for a missense mutation in fibulin - 5 ( FBLN5 ) results in a severe form of eutis laxa [ J ]. Hum Mol Genet, 2002,11 ( 18 ) : 2113 - 2118.
  • 6Carpentier YA, Portois L, Malaisse WJ. n - 3 fatty acids and the metabolic syndrome [ J ]. Am J Clin Nutr, 2006,83 (6 Suppl) : 1499S - 1504S.
  • 7Sijben JW, Calder PC. Differential immunomodulation with long - chain n-3 PUFA in health and chronic disease [J]. Proc Nutr Soc, 2007,66(2) :237 -259.
  • 8Tsuruga E, Yajima T, Irie K. Induction of fibulin -5 gene is reg- ulated by tropoelastin gene, and correlated with tropoelastin accu- mulation in vitro [ J]. Int J Biochem Cell Biol, 2004,36 (3) :395 - 400.
  • 9Albig AR, Schiemann WP. Fibulin -5 antagonizes vascular endo- thelial growth factor (VEGF) signaling and angiogenic sprouting by endothelial cells [ J]. DNA Cell Biol, 2004,23 (6) : 367 - 379.
  • 10Tu K, Dou C,Zheng X, et al. Fibulin - 5 inhibits hepatocellular carcinoma cell migration and invasion by down - regulating matrix metalloproteinase - 7 expression [ J/OL]. BMC Cancer, 2014, 14:938.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部